Eagle Pharmaceuticals
EGRX
#10415
Rank
HK$25.73 M
Marketcap
HK$1.96
Share price
0.00%
Change (1 day)
-79.54%
Change (1 year)

Market capitalization of Eagle Pharmaceuticals (EGRX)

Market cap: HK$25.73 Million

As of February 2026 Eagle Pharmaceuticals has a market cap of HK$25.73 Million. This makes Eagle Pharmaceuticals the world's 10415th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eagle Pharmaceuticals from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$25.73 M-43.28%
2025HK$45.37 M-18%
2024HK$55.33 M-89.57%
2023HK$0.53 B-82.15%
2022HK$2.97 B-42.03%
2021HK$5.12 B9%
2020HK$4.70 B-26.24%
2019HK$6.37 B45.28%
2018HK$4.38 B-29.51%
2017HK$6.22 B-34.59%
2016HK$9.52 B-11.4%
2015HK$10.74 B536.79%
2014HK$1.68 B

End of Day market cap according to different sources

On Feb 26th, 2026 the market cap of Eagle Pharmaceuticals was reported to be:

N/A
by Nasdaq info icon info icon
HK$25.73 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.672 T 18,156,263.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.557 T 9,936,260.95%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
HK$7.704 T 29,937,427.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.632 T 6,342,006.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$994.65 B 3,864,967.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$928.12 B 3,606,427.58%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$307.65 B 1,195,381.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel